Intel & Memory Stocks Surge… And Protagonist CEO On Drug Approval 5/5/26
About this episode
Semi stocks soaring, as Intel and memory names jump double digits. How much more this trade can climb, and how our traders are positioning in the chip rip. Plus, Meta’s copyright complications, Coinbase cuts heads as AI shakes up the workforce, and the CEO of biopharma company Protagonist on its recent drug approval and the stock’s big run up over the past year.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time CNBC's "Fast Money" publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from CNBC's "Fast Money"
Oracle Reports Results… And Mortgage Rates Top 7% 9/10/26
CNBC's "Fast Money"
Yields Surge, Stocks Fall… And Apple’s Foldable Phone 9/9/26
CNBC's "Fast Money"
Meta’s Latest AI Agent… And An AI-Powered Hedge Fund 9/8/26
CNBC's "Fast Money"
Markets look past strong jobs report... And tech’s next earnings test 9/4/26
CNBC's "Fast Money"